Even as a wave of clinical trial wins bolsters its momentum, Merck & Co. is prioritizing ongoing pipeline and commercial ...

For that indication, Rytelo is dosed at 7.1 mg/kg administered as an intravenous infusion every four weeks. Thrombocytopenia ...

As the commercial momentum behind Lilly’s tirzepatide franchise continues, analysts are increasingly turning their attention ...

Roughly one year into launch, Lenz Therapeutics, the maker of Vizz eye drops fo | In a massive overhaul of its operating ...

Several months after telegraphing a major antibody-drug conjugate manufacturing expansion in its native Switzerland, CDMO ...

Saved by the Bell” actor Mark-Paul Gosselaar is the new face (and name) of AstraZeneca’s biomarker testing push, “Meet Your ...

Bristol Myers Squibb executives faced sharp questions from an analyst on Thursday regarding the slow commercial launch pace of its highly touted Cobenfy. | BMS' novel-mechanism schizophrenia drug, ...

Stopping short of a formal declaration allowing their use, Department of Health and Human Services secretary Robert F. Kennedy Jr. | Stopping short of a formal declaration allowing their use, ...

After decades of being put on the backburner, women across the U.S. are “still waiting” to trust healthcare systems, a new ...

Pfizer’s Elrexfio has taken another step on its path to potential commercial momentum: The drugmaker just announced another ...

Eli Lilly is consolidating its U.S. and international commercial divisions into a unified department, tapping current U.S.

Amgen has been handed an FDA warning letter over a video promoting its cancer drug Vectibix, but the company said the issues ...